Financial institutions ill equipped to deal with credit risk developments, says D’Silva

D'Silva said the changing focus on credit risk from the "underwrite and hold” to the “underwrite and distribute” approach (using credit derivatives to distribute risk) has produced a new level of risk management concern both for banks and other financial institutions. Many firms do not have the management information systems to support firm-wide risk assessment, D’Silva added. This was particularly apparent for banks that had evolved out of mergers and acquisitions.

The increase in the types of firms using credit derivatives over the past few years has also brought new risk management issues to the market, D’Silva told delegates at the conference, organised by Toronto-based risk management technology vendor Algorithmics.

"We spoke with two insurance companies that have been involved in credit derivatives," D'Silva said. "When they talked about the size of their exposure it came as a shock to us. They weren't doing too well handling this and that's why they came to us."

D’Silva’s remarks are a reminder that regulators have become worried about the ability of insurance companies to effectively manage credit derivatives. In a speech in January, Howard Davies, head of the UK’s Financial Services Authority, quoted an investment banker who had quipped that synthetic collateralised debt obligations and other derivatives used by insurers are “the most toxic element of the financial markets today”.

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: